Prevalence of Sarcopenia in Cancer Patients: Review and Future Directions

@article{Morishita2016PrevalenceOS,
  title={Prevalence of Sarcopenia in Cancer Patients: Review and Future Directions},
  author={Shinichiro Morishita},
  journal={International Journal of Physical Medicine and Rehabilitation},
  year={2016},
  volume={4},
  pages={1-8}
}
  • S. Morishita
  • Published 19 May 2016
  • Medicine
  • International Journal of Physical Medicine and Rehabilitation
Background: Sarcopenia, or skeletal muscle loss, is a common problem in post-treatment cancer patients and can negatively affect physical function and quality of life (QOL). This condition has recently received special attention in the cancer literature because it is associated with reduced physical activity and increased mortality in patients with cancer. The aim of this brief review was to evaluate the prevalence of sarcopenia in cancer patients. Methods: A comprehensive literature search was… Expand
Assessment and Impact of Phase Angle and Sarcopenia in Palliative Cancer Patients
TLDR
The results corroborate the reliability of sarcopenia and phase angle in Mexican population, showing that the measurement of these parameters might also be useful in early-stage cancer patients as prognostic markers. Expand
The prevalence of sarcopenia is markedly increased in patients with intestinal failure and associates with several risk factors.
TLDR
Patients with intestinal insufficiency and intestinal failure are at immense risk of developing sarcopenia and associated risk factors are excessive alcohol consumption, intestinal failure, and inflammatory activity. Expand
Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer
TLDR
Sarcopenia appears to be a better predictor of OS than low SMM or low MF separately, according to a retrospective study in elderly HNSCC patients treated between 2015 and 2018. Expand
Muscle Hypertrophy in Cancer Patients and Survivors via Strength Training. A Meta-Analysis and Meta-Regression.
TLDR
Resistance training can counteract the loss of muscle mass in cancer patients, Especially in a supervised setting. Expand
Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy
TLDR
Baseline SMI has an impact on prognosis in patients who undergoing second-line chemotherapy for pancreatic cancer, and may warrant consideration as a predictive factor with which to identify candidates for second- line chemotherapy for advanced pancreaticcancer. Expand
Assessment and Impact of Phase Angle and Sarcopenia in Palliative Cancer Patients.
ABSTRACTSarcopenia has been evaluated as a separate condition in cancer patients and as an important indicator of adverse outcomes. Muscle mass and phase angle are usually quantified by bioelectric...
Redefining the perioperative stress response: a narrative review.
TLDR
It is suggested that a more nuanced understanding of changes in hypothalamic-pituitary-adrenal axis physiology is warranted to advance perioperative medicine through enhancing the understanding of the neuroendocrine aspects of preparation for and recovery from surgery. Expand
Sarkopenie − Diagnostik und mögliche Therapien
TLDR
The understanding of the concept and treatment of sarcopenia has already been improved, but research findings have not yet been translated into clinical practice, so insights into treatment methods are provided. Expand
Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
TLDR
Assessment of body composition changes during neoadjuvant chemotherapy and their association with postoperative complications is investigated to predict postoperative outcomes in patients with gastro‐oesophageal cancer. Expand
Capacidade funcional e dependência nicotínica em fase pré-tratamento oncológico de pacientes com câncer de pulmão
O câncer de pulmao acomete principalmente pessoas acima de 60 anos e tem relacao direta com o tabagismo, suas manifestacoes clinicas sao associadas a fadiga e descondicionamento fisico, gerandoExpand
...
1
2
...

References

SHOWING 1-10 OF 82 REFERENCES
Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study
TLDR
Sarcopenia is associated with an increased risk of overall mortality in breast cancer survivors and may be associated with breast-cancer-specific mortality, and the development of effective interventions to maintain and/or increase skeletal muscle mass to improve prognosis in cancer survivors warrants further study. Expand
Sarcopenia and physical function in overweight patients with advanced cancer.
TLDR
This work investigated the prevalence of sarcopenia and its association with different portable and low-cost functional status measurement tools in overweight/obese patients (body mass index ≥ 25 kg/m2) with advanced cancer. Expand
Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma
TLDR
Sarcopenia is present in almost one third of patients with HCC, and constitutes a strong and independent risk factor for mortality, highlighting the importance of body composition assessment in clinical practice. Expand
Sarcopenia and physical function in overweight patients with advanced cancer.
TLDR
Handgrip strength was associated with sarcopenia in male patients with advanced cancer, and therefore it may be used as a portable and simple nutritional screening tool. Expand
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
TLDR
Evidence is provided of the great variability of body composition in patients with cancer and links body composition, especially sarcopenic obesity, to clinical implications such as functional status, survival, and potentially, chemotherapy toxicity. Expand
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
TLDR
Sarcopenia in overweight/obese patients with advanced pancreatic cancer is an occult condition but can be identified using CT scans and is an independent adverse prognostic indicator that should be considered for stratification of patients' entering clinical trials, systemic therapy, or support care programs. Expand
Epidemiology of sarcopenia among the elderly in New Mexico.
TLDR
Some of the first estimates of the extent of the public health problem posed by sarcopenia are provided, independent of ethnicity, age, morbidity, obesity, income, and health behaviors. Expand
Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service
Background Body weight and body composition are relevant to the outcomes of cancer and antineoplastic therapy. However, their role in Phase I clinical trial patients is unknown. Methods We reviewedExpand
Sarcopenia as a predictor of complications and survival following radical cystectomy.
TLDR
Sarcopenia in women was a predictor of major complications after radical cystectomy after bladder cancer treatment, and further research confirming sarcopenia as a useful predictor of complications would support the development of targeted interventions to mitigate the untoward effects of sarc Openia before cancer surgery. Expand
Cancer cachexia update in head and neck cancer: Definitions and diagnostic features
TLDR
The prevalence of different clinical markers of cachexia at the time of diagnosis and before and after treatment is explored and recent findings, such as cardiac dysfunction, warrant clinical attention to more carefully identify patients at risk and potentially lead to better outcomes. Expand
...
1
2
3
4
5
...